@article{6b862c96fec041d59343b47052c34f93,
title = "Extravasation of diagnostic radiopharmaceuticals, a wolf in sheep's clothing?",
author = "{van der Pol}, {Jochem A J} and Mottaghy, {Felix Manuel}",
note = "Funding Information: Felix Mottaghy is a medical advisor for NanoMab Technology Ltd. and Advanced Accelerator Applications (AAA) GmbH; has recently received institutional grants from NanoMab Technology Ltd., Siemens, and GE Precision Healthcare LLC; and is supported by the German Research Foundation (DFG) within the framework of the Research Training Group 2375, “Tumor-Targeted Drug Delivery” (grant 331065168); the Clinical Research Unit CRU 5011, “Integrating Emerging Methods to Advance Translational Kidney Research (InteraKD)” (project 445703531); and the Research Unit 2591, “Severity Assessment in Animal-Based Research” (project 321137804). No other potential conflict of interest relevant to this article was reported.",
year = "2023",
month = mar,
day = "1",
doi = "10.2967/jnumed.122.265038",
language = "English",
volume = "64",
pages = "491--492",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine and Molecular Imaging",
number = "3",
}